Illumina Reports 163 Percent Jump in Q2 Sales; Raises Full-Year Guidance | GenomeWeb

NEW YORK, July 19 (GenomeWeb News) - Illumina yesterday reported a 163-percent surge in second-quarter revenues and swung into profitability from a loss in the second quarter of 2005.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.